Skip to main content
. 2026 Jul 21;19(7):1124. doi: 10.3390/ph19071124
5-ASA 5-aminosalicylic acid
ALP Alkaline phosphatase
ALT Alanine transaminase
AST Aspartate transaminase
Ca2+ Intracellular calcium
cAMP Cyclic adenosine monophosphate
CAT Catalase
CBWR Colon weight-to-body weight ratio
CD Crohn’s disease
COX-2 Cyclooxygenase-2
cPLA2 Cytosolic phospholipase A2
CRD Colorectal distension
DASR Disease activity score
DSS Dextran sodium sulfate
EMG Electromyography
eNOS Endothelial nitric oxide synthase
Gi/o proteins G inhibitory/other proteins
Gq Gq-protein coupled receptor
Gs protein Stimulatory G protein
GSH Reduced glutathione
GST Glutathione S-transferase
H1R Histamine H1 receptors
H2R Histamine H2 receptors
H2RA Histamine H2 receptor antagonist
H3R Histamine H3 receptors
H4R Histamine H4 receptors
HDC Histidine decarboxylase
IBD Inflammatory bowel disease
IFN-γ Interferon gamma
IL-17 Interleukin 17
IL-1β Interleukin 1β
IL-6 Interleukin 6
IP3 Inositol 1,4,5-trisphosphate
MC Microscopic colitis
MDA Malondialdehyde
MPO Myeloperoxidase
MTX Methotrexate
NADPH Nicotinamide adenine dinucleotide phosphate (reduced form)
NAFLD Non-alcoholic fatty liver disease
NF-κB Nuclear factor kappa- B
Nrf2 Nuclear factor erythroid 2-related factor 2 (Nrf2)
NSAID Non-steroidal anti-inflammatory drug
PGE2 Prostaglandin E2
p-IκBα Phosphorylated inhibitor of κb alpha
pKi Negative logarithm of the inhibition constant (Ki)
PLC Phospholipase C
PMSI Partial mayo scoring index
p-p65 Phosphorylated p65 subunit of NF-κb
PPIs Proton pump inhibitors
PSC Primary sclerosing cholangitis
PUFAs Polyunsaturated fatty acids
RAMH (R)-α-methylhistamine
ROS Reactive oxygen species
SOD Superoxide dismutase
STAT3 Signal transducer and activator of transcription 3
TAC Total antioxidant capacity
Th1 T helper 1 cells
Th17 T helper 17 cells
TNBS 2,4,6-trinitrobenzene sulfonic acid
TNF-α Tumor necrosis factor α
TOS Total oxidative status
UC Ulcerative colitis
VMRs Visceromotor responses